The Corn Lab

The Corn Lab develops and uses next-generation genome editing and regulation technologies. We work on both fundamental biological discovery and potential therapies for human genetic diseases. Our focus is the mechanisms by which cells repair their DNA, maintain and differentiate hematopoietic stem cells, and dispose of entire organelles. Through technology development, mechanistic cellular biochemistry, and translational projects, we are working to unravel complex cellular phenotypes to further biological understanding and improve human health.

Our work is supported by the Swiss National Science Foundation, the European Research Council, the NCCR RNA & Disease, the Fanconi Anemia Research Fund, the Bill and Melinda Gates Foundation, the NOMIS Foundation, and the Lotte and Adolf Hotz-Sprenger Foundation.

News

August 9, 2022

Congrats to Mandy on the BRIDGE grant!

Mandy received the BRIDGE Proof-of-Concept grant for her research on hemoglobin diseases. The BRIDGE programme is jointly offered by the Swiss National ...

March 15, 2022

Welcome to Martina

Martina received her BSc degree in Biochemistry at the Imperial College London, graduating in July 2020. She joined the Corn Lab in February 2022 and her Master...

March 15, 2022

Welcome to Simone

Simone received his Bachelor’s degree in Biotechnology in 2020, from the Università del Piemonte Orientale, Novara, Italy. He joined the Corn Lab in July ...

News Archive

Tweets

Contact Us

Questions and/or comments about Corn Lab and its activities may be addressed to:

JACOB.CORN@BIOL.ETHZ.CH

Share: